Search

everythinglearnresearchcommunity

for

Search:↓

Ayurveda offers ways to manage hair loss common in India.

Female pattern hair loss is common and affects quality of life, but more research is needed for better treatments.

COVID-19 may cause a common type of hair loss called telogen effluvium.

Fat tissue can potentially treat a common form of hair loss called androgenic alopecia.

Most women with excessive hair growth (hirsutism) also experience a common type of non-scarring hair loss called Androgenetic alopecia with telogen effluvium.

A girl with a rare genetic condition affecting hair and nails also developed a common type of hair loss, suggesting a possible genetic link.

Androgenetic alopecia (AGA) is a common, hereditary hair loss condition that can be slowed but not permanently reversed with available therapies.

Androgenetic alopecia is the most common cause of hair loss, affecting both men and women, with varying patterns and prevalence among different races.

Iron deficiency in women is common, often overlooked, and needs better recognition and treatment.

Hair loss in secondary syphilis is more common than thought and can be reversed with antibiotics.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Hair extensions can cause hair loss and scalp damage, and these problems might be more common than people realize.

Polycystic Ovary Syndrome (PCOS) is not very common among Iranian women, but it's important to prevent it because of the risk of heart disease and infertility.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Skin and hair-picking disorders are common and need both skin and mental health treatments.

Nonclassic 21-hydroxylase deficiency is a common, treatable genetic disorder causing reversible symptoms like acne and hair loss.

FFA in men, often mistaken for other hair loss types, may be more common than thought and needs larger studies for confirmation.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Idiopathic hirsutism is the most common cause, followed by PCOS, and insulin resistance should be checked in patients with acanthosis nigricans.

The study concluded that short vellus hair and yellow dots were the most common signs of alopecia areata, indicating disease activity and remission.

Hair loss was the most common skin issue among healthcare workers with COVID-19.

Hashimoto’s thyroiditis is more common in girls, often after puberty, and can cause neck swelling, fatigue, and hair loss.

PCOS phenotypes A and B are more common and linked to higher health risks in women from the Ecuadorian Andes.

Most patients use PRP for hair loss and facial rejuvenation with minor side effects.

Female pattern hair loss is common, often starts in the 30s or 40s, worsens after menopause, and can negatively affect quality of life.

Hair loss after COVID-19 is common, starts sooner in severe cases, and often comes with scalp pain.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

Non-scarring hair loss is common in children and needs attention for cosmetic reasons.

Iron deficiency is not more common in women with hair loss, and neurogenic rosacea may need different treatment.